2022 American Transplant Congress Archives

2:00pm-2:10pm: A Randomised Trial Of Normothermic Machine Perfusion Versus Static Cold Storage In Donation After Circulatory Death Renal Transplantation

S. Hosgood¹, C. Callaghan², C. Wilson³, G. Oniscu⁴, B. Phillips⁵, L. Bates³, L. Smith⁶, M. L. Nicholson⁷

Late Breaking: Clinical Trials • Hynes Ballroom B

2:10pm-2:20pm: Results Of The Ctot19 Trial: Infliximab (IFX) Induction Does Not Impact 2-year Outcomes In Deceased Donor Kidney Transplant Recipients

P. Heeger¹, B. Armstrong², T. Alhamad³, D. Brennan⁴, J. Bromberg⁵, S. Bunnapradist⁶, S. Chandran⁷, R. Fairchild⁸, D. Foley⁹, R. Formica¹⁰, I. W. Gibson¹¹, D. Hricik¹², K. Kesler², R. B. Mannon¹³, M. Menon¹⁰, K. Newell¹⁴, P. Nickerson¹¹, J. Odim¹⁵, E. Poggio⁸, R. Sung¹⁶, R. Shapiro¹, K. Tinckam¹⁷, F. Vincenti⁷

Late Breaking: Clinical Trials • Hynes Ballroom B

2:20pm-2:30pm: Ex Vivo End Ischemic Hypothermic Oxygenated Perfusion (hope) Versus Static Cold Storage Prior To Liver Transplantation – Preliminary Results Of The Bridge To Hope Pivotal Multicenter Randomized Controlled Clinical Trial On The Safety And Effectiveness Of The Vitasmart Liver Machine Perfusion System (clinicaltrials.gov: Nct05045794)

D. J. Reich¹, A. Schlegel², M. Rizzari³, D. Foley⁴, M. DeVera⁵, W. Chapman⁶, G. Roll⁷, A. Saharia⁸, C. Quintini⁹, S. Florman¹⁰, S. Merani¹¹, S. Mao¹², A. Pinna¹³, M. Akoad¹⁴, C. Kubal¹⁵, S. Alexopoulos¹⁶, H. Bohorquez¹⁷

Late Breaking: Clinical Trials • Hynes Ballroom B

2:30pm-2:40pm: A Randomized Phase 2 Study Of Mau868 Vs Placebo To Treat Bk Viremia In Kidney Transplant Recipients

S. Jordan¹, A. P. Limaye², B. Fischbach³, P. Sood⁴, S. Collette⁵, L. Gasink⁶, M. W. Fordyce⁷, C. J. Lin⁷, M. Hodges⁶, D. C. Brennan⁸

Late Breaking: Clinical Trials • Hynes Ballroom B

2:40pm-2:50pm: Single Blind Randomized Controlled Trial Comparing BNT162b2 Vs JNJ-78436735 Vaccine As An Additional Dose After Two Doses Of BNT162b2 Vaccine In Solid Organ Transplant (SOT) Recipients

Y. Natori¹, E. Martin², A. Mattiazzi³, J. Bini Viotti¹, K. S. Ortecho⁴, S. Pallikkuth⁵, S. Anjan¹, J. Simkins¹, G. Guerra³

Late Breaking: Clinical Trials • Hynes Ballroom B

2:50pm-3:00pm: Tacrolimus After Rabbit Antithymocyte Globulin And Infliximab Induction Immunosuppression In Kidney Transplantation

O. Viklicky¹, G. Bold², O. Bestard³, P. Hruba¹, I. Zahradka¹, N. M. Otto², M. Stein², A. Sefrin², S. Christakoudi⁴, P. M. Reinke²

Late Breaking: Clinical Trials • Hynes Ballroom B

5:30pm-7:00pm: 30-day Readmissions After Atrial Fibrillation Associated Hospitalizations in Kidney Transplant Recipients

N. Garg, N. Kumar

Kidney: Cardiovascular and Metabolic Complications • Hynes Halls C & D

5:30pm-7:00pm: A Dose Dependent Effect of Varying Tacrolimus Concentrations on Cytomegalovirus Viral Specific T Cell Interferon Gamma Expression

H. L. Kleiboeker¹, M. R. Jorgenson¹, R. O. Meyers², O. Ganz², S. Parajuli³, J. Galipeau⁴

All Infections (Excluding Kidney & Viral Hepatitis) I • Hynes Halls C & D

5:30pm-7:00pm: A Large-Scale National Cohort Study Assessing the Impact of Diabetes and Obesity on Kidney Transplant Outcomes

V. Rohan¹, M. Casey¹, S. Zemin², P. Baliga², D. Taber²

Kidney: Cardiovascular and Metabolic Complications • Hynes Halls C & D

5:30pm-7:00pm: A Model for Medical Device Innovation in Transplantation: Using the Biodesign Process to Address the Impact of Warm Ischemic Injury

K. Hansen¹, J. Wall²

Non-Organ Specific: Organ Preservation/Ischemia Reperfusion Injury • Hynes Halls C & D